Search
Showing results for "clinical trials"
Our team of world-class researchers and exceptional clinicians work in collaboration to provide children access to the very best evidence-based therapies and programs.
In response to DNA damaging chemotherapy, targeting MK2 in p53-mutated cells produces a phenotype that is distinct from the p53-deficient phenotype
We present a curated panel of 12 readily-usable, cell lines representing the spectrum of molecular subtypes of IDH-wildtype glioblastoma
A novel mouse model for glioma demonstrating that the PI3K pathway is important for initiation of tumorigenesis
Increased maternal egg ingestion is associated with increased breastmilk ovalbumin, and markers of immune tolerance in infants
Information about cystic fibrosis awareness month and CF research at The Kids
Neuroblastoma is a complex childhood cancer of the nerve cells and the most common solid tumour in children outside of the brain. The average age of diagnosis is 1-2 years and tragically 50% of children with high-risk neuroblastoma lose their battle within five years.
We are developing a gel that can be left behind in the wound bed after sarcoma surgery.
The aim was to document the aetiology of acute lower respiratory infection (ALRI) hospitalisations in Western Australian children
We have developed an LC-MS/MS assay that accurately measures saliva 25(OH)D3 levels, which correlated with serum levels